|
|
||||||||
J Thorac Cardiovasc Surg 2003;125:S80-S81
© 2003 The American Association for Thoracic Surgery
Editorials |
From the Department of Thoracic/Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio.
Received for publication Nov 22, 2000. Accepted for publication Dec 13, 2000. Address for reprints: Bruce W. Lytle, MD, Department of Thoracic/Cardiovascular Surgery, The Cleveland Clinic Foundation, 9500 Euclid Ave, F-25, Cleveland, OH 44195.
| The first 20% of the full text of this article appears below. |
| Editorial note |
|---|
Enabling technology alters the way we do things: sometimes for the better (enduring technology) and sometimes not for the better (evanescent technology). Occasionally, new technologies that do not endure are steps in the direction of advances that will ultimately become part of our therapeutic options. Whereas new pharmacologic agents can usually be rapidly dispersed and their use can be well described in text, advances in technology are more complex to disseminate. Ideally, one would like to minimize the "learning curve"
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |